Andres G Barboza1, Edgar Carnero Contentti2, Maria Celeste Curbelo3, Mario Javier Halfon3,4, Juan Ignacio Rojas5, Berenice A Silva6, Vladimiro Sinay7, Santiago Tizio8, Maria Celica Ysrraelit9, Ricardo Alonso6,10. 1. Servicio de Neurologia, Hospital Central de Mendoza, España 120, 5500, Mendoza, Argentina. agbarboza@gmail.com. 2. Neuroimmunology Unit, Department of Neuroscience, Hospital Alemán, Buenos Aires, Argentina. 3. MS Section Hospital Britanico Buenos Aires, Buenos Aires, Argentina. 4. Hospital Municipal de Vicente López Prof. Dr. Bernardo Houssay, Buenos Aires, Argentina. 5. Centro de Esclerosis Múltiple de Buenos Aires, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. 6. Clínica de Esclerosis Múltiple, Hospital Ramos Mejía, Buenos Aires, Argentina. 7. Fundación Favaloro/INECO, Buenos Aires, Argentina. 8. Hospital Español de La Plata, La Plata, Argentina. 9. Department of Neurology, Institute for Neurological Research Dr. Raul Carrea, FLENI, Buenos Aires, Argentina. 10. Sanatorio Guemes, Buenos Aires, Argentina.
Abstract
BACKGROUND: Technological advances and greater availability of magnetic resonance imaging have prompted an increment on incidental and unexpected findings within the central nervous system. The concept of radiologically isolated syndrome characterizes a group of subjects with images suggestive of demyelinating disease in the absence of a clinical episode compatible with multiple sclerosis. Since the description of this entity, many questions have arisen; some have received responses but others remain unanswered. A panel of experts met with the objective of performing a critical review of the currently available evidence. Definition, prevalence, biological bases, published evidence, and implications on patient management were reviewed. Thirty to 50% of subjects with radiologically isolated syndrome will progress to multiple sclerosis in 5 years. Male sex, age < 37 years old, and spinal lesions increase the risk. These subjects should be evaluated by a multiple sclerosis specialist, carefully excluding alternative diagnosis. An initial evaluation should include a brain and complete spine magnetic resonance, visual evoked potentials, and identification of oligoclonal bands in cerebrospinal fluid. Disease-modifying therapies could be considered when oligoclonal bands or radiological progression is present. CONCLUSION: At present time, radiologically isolated syndrome cannot be considered a part of the multiple sclerosis spectrum. However, a proportion of patients may evolve to multiple sclerosis, meaning it represents much more than just a radiological finding.
BACKGROUND: Technological advances and greater availability of magnetic resonance imaging have prompted an increment on incidental and unexpected findings within the central nervous system. The concept of radiologically isolated syndrome characterizes a group of subjects with images suggestive of demyelinating disease in the absence of a clinical episode compatible with multiple sclerosis. Since the description of this entity, many questions have arisen; some have received responses but others remain unanswered. A panel of experts met with the objective of performing a critical review of the currently available evidence. Definition, prevalence, biological bases, published evidence, and implications on patient management were reviewed. Thirty to 50% of subjects with radiologically isolated syndrome will progress to multiple sclerosis in 5 years. Male sex, age < 37 years old, and spinal lesions increase the risk. These subjects should be evaluated by a multiple sclerosis specialist, carefully excluding alternative diagnosis. An initial evaluation should include a brain and complete spine magnetic resonance, visual evoked potentials, and identification of oligoclonal bands in cerebrospinal fluid. Disease-modifying therapies could be considered when oligoclonal bands or radiological progression is present. CONCLUSION: At present time, radiologically isolated syndrome cannot be considered a part of the multiple sclerosis spectrum. However, a proportion of patients may evolve to multiple sclerosis, meaning it represents much more than just a radiological finding.
Authors: M Tintoré; A Rovira; M J Martínez; J Rio; P Díaz-Villoslada; L Brieva; C Borrás; E Grivé; J Capellades; X Montalban Journal: AJNR Am J Neuroradiol Date: 2000-04 Impact factor: 3.825
Authors: Nicola De Stefano; Eleonora Cocco; Marina Lai; Marco Battaglini; Andrea Spissu; Piernicola Marchi; Gianluca Floris; Marzia Mortilla; Maria L Stromillo; Andrea Paolillo; Antonio Federico; Maria Giovanna Marrosu Journal: Ann Neurol Date: 2006-04 Impact factor: 10.422
Authors: D T Okuda; E M Mowry; A Beheshtian; E Waubant; S E Baranzini; D S Goodin; S L Hauser; D Pelletier Journal: Neurology Date: 2008-12-10 Impact factor: 9.910
Authors: Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen Journal: Lancet Neurol Date: 2017-12-21 Impact factor: 44.182
Authors: Andrew J Solomon; Dennis N Bourdette; Anne H Cross; Angela Applebee; Philip M Skidd; Diantha B Howard; Rebecca I Spain; Michelle H Cameron; Edward Kim; Michele K Mass; Vijayshree Yadav; Ruth H Whitham; Erin E Longbrake; Robert T Naismith; Gregory F Wu; Becky J Parks; Dean M Wingerchuk; Brian L Rabin; Michel Toledano; W Oliver Tobin; Orhun H Kantarci; Jonathan L Carter; B Mark Keegan; Brian G Weinshenker Journal: Neurology Date: 2016-08-31 Impact factor: 9.910
Authors: J I Rojas; L Patrucco; J MIguez; V Sinay; F Pagani Cassara; F Cáceres; N Fernandez Liguori; M L Saladino; N Deri; G Jaacks; M Parada Marcilla; M I Arrigoni; J Correale; M Fiol; M C Ysrraelit; A Carrá; M C Curbelo; A Martinez; J Steinberg; S Bestoso; J P Hryb; J L Di Pace; M B Perassolo; E Carnero Contentti; A Caride; P A Lopez; C Martinez; E Reich; E Cristiano Journal: Mult Scler Relat Disord Date: 2016-01-19 Impact factor: 4.339
Authors: Y Forslin; T Granberg; A Antwan Jumah; S Shams; P Aspelin; M Kristoffersen-Wiberg; J Martola; S Fredrikson Journal: AJNR Am J Neuroradiol Date: 2016-02-04 Impact factor: 3.825
Authors: Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2005-12 Impact factor: 10.422
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: Maria Pia Amato; Nicola De Stefano; Matilde Inglese; Emanuele Morena; Giovanni Ristori; Marco Salvetti; Maria Trojano Journal: Front Neurol Date: 2022-03-14 Impact factor: 4.003